GRCE
Grace Therapeutics·NASDAQ
--
--(--)
--
--(--)
GRCE fundamentals
Grace Therapeutics (GRCE) released its earnings on Aug 12, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.21 (YoY +12.50%), beat estimates.
Revenue / YoY
0
--
EPS / YoY
-0.21
+12.50%
Report date
Aug 12, 2025
EPS
Actual | -2.4 | -2.88 | -1.44 | -1.44 | -0.48 | -0.18 | -0.54 | -0.54 | -0.6 | -0.66 | -0.54 | -3.9 | -0.54 | -0.43 | -0.21 | -0.17 | -0.24 | -0.3 | -0.36 | 0.11 | -0.21 | ||||||||
Forecast | -2.7871 | -2.6467 | -1.92 | -1.92 | -0.48 | -0.78 | -0.74 | -0.84 | -0.28 | -0.26 | -0.23 | -0.35 | -0.265 | -0.37 | -0.335 | -0.2775 | -0.22 | ||||||||||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +13.89% | -8.81% | +25.00% | +25.00% | 0.00% | 0.00% | -12.50% | +30.77% | 0.00% | 0.00% | +27.03% | -364.29% | -92.86% | -65.38% | +8.70% | +51.43% | +9.43% | +18.92% | -7.46% | +139.64% | +4.55% |
Revenue
Actual | -- | -- | -- | -- | -- | -- | -- | -- | 0 | -- | 81.00K | -- | -- | -- | -- | -- | -- | 0 | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Forecast | -- | -- | -- | -- | -- | -- | -- | -- | 0 | 0 | 0 | 0 | -- | -- | -- | -- | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
What does Grace Therapeutics do and what are its main business segments?What is the market's earnings forecast for Grace Therapeutics next quarter?What guidance did Grace Therapeutics's management provide for the next earnings period?What is Grace Therapeutics's gross profit margin?What is Grace Therapeutics's latest dividend and current dividend yield?What factors drove the changes in Grace Therapeutics's revenue and profit?Did Grace Therapeutics beat or miss consensus estimates last quarter?What were the key takeaways from Grace Therapeutics's earnings call?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
